The 2nd “Danube Symposium” meeting, together with the 3rd CBmed Biomarker Conference, intended to provide a forum to open-minded experts both from academia and industry in the field of molecular pathology, laboratory medicine, nuclear medicine, clinical pharmacology and beyond who share this vision and like to engage in advancing effective and individualized treatments based on […]
Shahrokh F. Shariat, Head of the Department of Urology, initiated the meeting “Frontiers in Urology” in December 2017 and invited international pioneers and experts to talk about current treatment options of urological disease including Yair Lotan, Ganesh S. Palapattu, Arkadiusz Miernik and Domenico Veneziano.The program focuses on key clinical topics in the management of urological […]
On February the 1st, 2018 our first Scientific Advisory Board Meeting took place. Five internationally renowned experts visited our institute with the purpose to evaluate and review our research.The meeting started with a welcome note by Vice Rector Dipl.-Ing. Dr Michaela Fritz. She emphasised the importance of personalised and translational medicine as well as the […]
24th – 27th January 2018, the LBI:AD was part of the 33rd International Austrian Winter Symposium that was organized by the Austrian Society of Nuclear Medicine & Molecular Imaging together with the 13th ALPE ADRIA Nuclear Medicine Symposium. Traditionally, the scientific event was supported by the wonderful atmosphere of Zell am See, Austria.An intriguing start […]
The European Association of Nuclear Medicine (EANM) meets annualy in an European city to discuss the newest trends and findings in the field of nuclear medicine. The EANM congress provides great possibilities to network and socialise while learning about the scientific progress in different countries and research institutes.This year’s EANM took place during the 21st […]
Between the 19th and 20th of October 2017 the opening and scientific symposium of the Austrian Platform for Personalized Medicine took place. The Medical University of Vienna started a huge fundraising campaign to raise awareness of precision medicine and to develop the new research center at the Campus of the Medical University/General hospital in Vienna. […]
Prof. Dr. Thomas L. Mindt, Head of Imaging Biomarkers, was invited to deliver the plenary lecture at the 4th national congress of the Korean Society of Radiopharmaceuticals and Molecular Probes (KSRAMP) 2017 in Daejeon, Korea.His presentation was entitled “Of Established and Emerging Radiometals” and included an overview on the use of new radionuclides (e.g., Zr-89, […]
(Wien, 17-10-2017) Johannes Längle von der Klinischen Abteilung für Allgemeinchirurgie der Universitätsklinik für Chirurgie der MedUni Wien/AKH Wien wurde bei der diesjährigen 34. Jahrestagung der Österreichische Gesellschaft für Chirurgische Onkologie (ACO-ASSO) mit einem Posterpreis ausgezeichnet.Die Studie hatte den Titel „DNA damage, DNA sensor DDX41 and ER stress response predict prognosis and treatment response in colorectal […]
Beim LBG Weinherbst am 11. Oktober 2017 stellte die Ludwig Boltzmann Gesellschaft zwei Forschungsgruppen vor, die sich mit der psychischen Gesundheit von Kindern mit psychisch erkrankten Eltern befassen werden. Die international und interdisziplinär – von Psychologie über Computer- bis Theaterwissenschaften – besetzten Teams haben sich in einem “Ideas Lab” formiert und ihre Konzepte für die […]
Ms. Mag. Nathalie Grob, who is currently a Ph.D. student (ETH Zurich and Paul Scherrer Institut in Villigen (CH)) of LBI:AD key researcher Prof. Mindt, won at the 25th annual meeting of the “Arbeitsgemeinschaft Radiochemie/ Radiopharmazie” in Starnberg, Germany, the AGRR-2017 award for the best presentation in the category young researcher. She presented her research […]
